Evidence map›Paper›PMID 32053684›Full record

ArticlePloS one2020

Cryptosporidium spp.: Human incidence, molecular characterization and associated exposures in Québec, Canada (2016-2017).

Juliana Ayres Hutter, Réjean Dion, Alejandra Irace-Cima, Marc Fiset, Rebecca Guy, Brent Dixon, Jeannie Lisette Aguilar, Julien Trépanier, Karine Thivierge

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Prevalence of human cryptosporidiosis in the Americas: systematic review and meta-analysis.Revista do Instituto de Medicina Tropical de Sao Paulo · 2022
    Pooled it
  2. Large-scale molecular epidemiological survey ofJournal of clinical microbiology · 2026
    Article
  3. Advancing genomics for waterborne pathogen surveillance in Australia.The Lancet regional health. Western Pacific · 2026
    Review
  4. First nationwide investigation ofCurrent research in parasitology & vector-borne diseases · 2025
    Article
  5. Review
  6. Article
  7. Identification and Evaluation ofMicrobiology spectrum · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Identification and Subtyping ofIranian journal of parasitology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Juliana Ayres HutterDirection des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Montréal, Québec, Canada.
Réjean DionLaboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
Alejandra Irace-CimaDirection des risques biologiques et de la santé au travail, Institut national de santé publique du Québec, Montréal, Québec, Canada.
Marc FisetDirection de la vigie sanitaire, Ministère de la Santé et des Services sociaux, Québec, Québec, Canada.
Rebecca GuyNational Microbiology Laboratory at Guelph, Public Health Agency of Canada, Guelph, Ontario, Canada.
Brent DixonBureau of Microbial Hazards, Food Directorate, Health Canada, Ottawa, Ontario, Canada.
Jeannie Lisette AguilarLaboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.
Julien TrépanierLaboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.ORCID 0000-0003-0373-087X
Karine ThiviergeLaboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada.ORCID 0000-0002-8291-5081
Institut National de Santé Publique du Québec · CAHealth Canada · CAMinistry of Health and Social Services · CAPublic Health Agency of Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to describe the epidemiology of human cryptosporidiosis in Québec from 2016 to 2017 and to identify possible exposures associated with the disease, and the dominant Cryptosporidium species in circulation. A descriptive analysis was performed on data collected from the provincial notifiable infectious diseases registry and the epidemiological investigation. Fecal sample were sent to the Laboratoire de santé publique du Québec for molecular characterization. In Québec, from January 1, 2016 to December 31, 2017, a total of 201 confirmed cases of cryptosporidiosis were notified. A peak in the number of reported cases was observed at the end of the summer. The regional public health department with the highest adjusted incidence rate for sex and age group for both years was that of Nunavik, in the north of Québec. A higher average annual incidence rate was observed for females between the ages of 20 to 34 years compared to males. Overall, for both males and females the distribution appeared to be bimodal with a first peak in children younger than five years old and a second peak in adults from 20 to 30 years of age. Molecular characterization showed that 23% (11/47) of cases were infected with C. hominis while 74% (35/47) were infected with C. parvum. Meanwhile, subtyping results identified by gp60 sequencing, show that all C. parvum subtypes belonged to the IIa family, whereas the subtypes for C. hominis belonged to the Ia, Ib, and Id families. Finally, the epidemiological investigation showed that diarrhea was the most common reported symptom with 99% (72/73) of investigated cases having experienced it. This first brief epidemiological portrait of cryptosporidiosis in Québec has allowed for the description, both at the provincial and regional level, of the populations that could be particularly vulnerable to the disease.

Indexed as

AdultCanadaCryptosporidiosisFemaleHumansIncidenceMalePublic HealthQuebecYoung Adult

Identifiers

PMID32053684
PMCPMC7018055
OpenAlexW3005636948

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.